Stocktoria
BIOCRYST PHARMACEUTICALS INC BCRX
BIOCRYST PHARMACEUTICALS INC institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 19,956,255 | $123.3M | 9.13% |
| TWO SIGMA INVESTMENTS, LP | 6,775,349 | $67.8M | 3.1% |
| MILLENNIUM MANAGEMENT LLC | 3,394,729 | $33.9M | 1.55% |
| RENAISSANCE TECHNOLOGIES LLC | 2,530,290 | $25.3M | 1.16% |
| AQR CAPITAL MANAGEMENT LLC | 2,214,302 | $22.1M | 1.01% |
| CITADEL ADVISORS LLC | 2,136,360 | $21.4M | 0.98% |
| Bridgewater Associates, LP | 491,057 | $4.9M | 0.22% |
| D. E. Shaw & Co., Inc. | 408,529 | $4.1M | 0.19% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.